PLK1, a potential novel therapeutic target for lupus
Search Results
You searched for: lupus nephritis
Results found: 1120
IDO2, a novel therapeutic target for the treatment of lupus
Being Smart About Research
When it comes to solving the mysteries of lupus, we must explore all potential avenues of discovery—including the brain.
This...
A Promising New Therapy
April, 2019
As our name implies, the Lupus Research Alliance aims to forge partnerships and bring other players to the...
Tell Congress Why Lupus Research Funding Must be a Priority
With your help, the Lupus Research Alliance has become the world’s largest funder of lupus research. The Lupus Research...
Influence of BANK1 in the in vivo development of lupus
House Appropriations Committee Supports Lupus ABC
Great news! With a unanimous, bipartisan vote, the House Appropriations Committee adopted a provision supporting the Lupus Accelerating Breakthroughs...
Lupus Industry Council
The Lupus Research Alliance Lupus Industry Council (LIC) includes pharmaceutical and biotechnology companies working together in the pre-competitive space...
Sex hormones, dendritic cells, and the IFN signature in lupus
Forum for Discovery
April, 2019
In November, top-flight research scientists, pharmaceutical industry representatives, and advocates met in New York City to take part...
Lupus Therapeutics, LLC
The Lupus Research Alliance established Lupus Therapeutics in 2018 to support the clinical research of potential new treatments for...
Lupus Research Alliance Salutes Congress for Passing the 21st Century Cures Act — #CuresNow
The Lupus Research Alliance proudly announces that the last major hurdle to the 21st Century Cures Act has been...